Dravet Diary Mobile vs Carepsy - Tracker & Treatment Kullanım & İstatistikleri

The Dravet Diary App is the first diary dedicated to people with Dravet Syndrome, a severe form of epilepsy. The Diary is a tool that allows you to record and document in detail the crises that occur, how often, during which therapy, the state of health of the subject at that time and other useful information. The application allows doctors who treat patients to be able to consult the data and, on the basis of this information, define the related therapies to be implemented.
  • Apple App Store
  • BOŞTA
  • Sağlık ve Fitness

Mağaza Sıralaması

- -

Carepsy is an app which allows you to quickly document daily variables concerning your epilepsy, such as seizure triggers, types, mood, warning sign, etc... The information you provide is organized into easy to read graphs which allow for quick visualization of your individual epilepsy trends and patterns overtime. This app can serve as a valuable communication aid, by allowing you to generate a straightforward and professional report. App Features: - Easy to use - Record seizure details (as much or as little as you like) - Visual representation of data - Generate reports (Moods, Duration, Time of day, Top triggers, Warning Sign, Event Symptom, Post Event Symptom) - Keep track of medications with reminders
  • Apple App Store
  • Ücretliler
  • Medikal

Mağaza Sıralaması

- -

Dravet Diary Mobile ile Carepsy - Tracker & Treatment için sıralama karşılaştırması

Son 28 gündeki Dravet Diary Mobile sıralama trendini Carepsy - Tracker & Treatmentile karşılaştırın

Rank

Mevcut veri yok

Dravet Diary Mobile vs. Carepsy - Tracker & Treatment ülke karşılaştırmasına göre sıralama

Son 28 gündeki Dravet Diary Mobile sıralama trendini Carepsy - Tracker & Treatmentile karşılaştırın

Tüm kategoriler

Mevcut veri yok

Sağlık ve Fitness

Uygulama
En İyi Ülke
Sıralama
- -
- -
#42

Ücretsiz deneme sürümümüzü kullanarak istediğiniz siteyle karşılaştırın

Başlayın
Dravet Diary Mobile VS.
Carepsy - Tracker & Treatment

Mart 16, 2025